' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

[Tumour recurrence].
Hakenberg, OW; Sedlmayer, F;
UROLOGE. 2010; 49(2): 228-232.
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

Sedlmayer Felix

Abstract

In Chap. 6 the German S3 guideline on prostate cancer addresses the issue of tumour recurrence following primary local treatment with curative intent, i.e. after radical prostatectomy or a form of radiotherapy. PSA recurrence after radical surgery is defined as a rising PSA of 0.2 ng/ml and after radiotherapy as an increase of at least 2 ng/ml above the individual nadir. Factors for the clinical judgement that a local recurrence is likely are empirical indicators from the primary tumour diagnosis and the PSA course after primary treatment. Salvage external beam radiotherapy after radical surgery does not require the histological proof of a local recurrence and should be initiated early (PSA < 0.5 ng/ml). Before salvage radical prostatectomy, which carries a higher complication rate, the presence of a local recurrence should be histologically verified.


Useful keywords (using NLM MeSH Indexing)

Evidence-Based Medicine*

Humans

Male

Neoplasm Recurrence, Local/mortality

Neoplasm Recurrence, Local/pathology

Neoplasm Recurrence, Local/therapy*

Practice Guidelines as Topic*

Prostate/pathology

Prostate-Specific Antigen/blood

Prostatectomy

Prostatic Neoplasms/mortality

Prostatic Neoplasms/pathology

Prostatic Neoplasms/therapy*

Radioisotope Teletherapy

Salvage Therapy

Survival Rate

Tumor Markers, Biological/blood


Find related publications in this database (Keywords)

Radical prostatectomy
Radiotherapy
Recurrence
Salvage treatment